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Microsatellite instability in ovarian neoplasms
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Summary Microsatellite instability has been observed in a variety of sporadic malignancies, but its existence
in sporadic ovarian cancer has been the subject of conflicting reports. We have performed a polymerase chain
reaction-based microsatellite analysis of DNAs extracted from the neoplastic and non-neoplastic tissues of 41
ovarian cancer patients. Tumour-associated alterations were observed in seven (17%) of these cases.
Clinicopathological correlations revealed that: (1) alterations among tumours classified as serous adenocar-
cinomas occurred with relatively low frequency (2/24 or 8%); (2) most of the tumours with microsatellite
alterations (5/7 or 71%) were of less common histopathological types (epithelial subtypes such as endometrioid
and mixed serous and mucinous, or non-epithelial types such as malignant mixed Mullerian or germ cell
tumours); (3) tumour-associated alterations were observed in 3/4 (75%) of the patients with stage I tumours vs
4/37 (11%) of the patients with stage II, III and IV tumours (P = 0.01); (4) tumour-associated microsatellite
instability was found to occur with similar frequencies among patients with and without clinical features
suggestive of familial disease, including positive family history, early onset, or multiple primary tumours. In
summary, we have observed microsatellite alterations in the neoplastic tissues of ovarian cancer patients with
diverse genetic backgrounds and clinicopathological features. The pattern of alterations is consistent with the
possibility that multiple mechanisms may be responsible for microsatellite instability in ovarian neop-
lasms.
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Microsatellites are widely distributed repetitive DNA
sequences composed of short, tandemly repeated nucleotide
motifs. In some neoplasms, these sequences exhibit a form of
genetic instability characterised by the gain or loss of repeat
units at multiple independent loci. Such alterations have been
observed to accumulate in cells defective for DNA repair
activities (Parsons et al., 1993; Umar et al., 1994a) and occur
with highest frequency in association with the familial cancer
syndrome HNPCC (hereditary non-polyposis colorectal
cancer) (Aaltonen et al., 1993; Peltomaki, et al., 1993; Ris-
inger et al., 1993). HNPCC families are characterised by a
high frequency ofcolorectal and extracolonic malignancies of
the gastrointestinal, upper urological and female genital
tracts, often with early age of onset (Lynch et al., 1993;
Watson and Lynch, 1993). Human homologues of bacterial
and yeast DNA mismatch repair genes have been located on
chromosomes 2 (hMSH2, hPMS1), 3 (hMLHI) and 7
(hPMS2), and mutations have been identified at these loci in
HNPCC patients (Fishel et al., 1993; Leach et al., 1993;
Bronner et al., 1994; Kolodner et al., 1994, 1995; Liu et al.,
1994; Lynch et al., 1994; Mary et al., 1994; Nicolaides et al.,
1994; Papadopoulos et al., 1994; Han et al., 1995).
Microsatellite instability has also been observed in a varie-
ty of sporadic malignancies, including those of the colon,
endometrium, stomach, pancreas, lung, bladder, kidney,
oesophagus, and haematopoietic system (Gonzalez-Zulueta et
al., 1993; Han et al., 1993; Ionov et al., 1993; Risinger et al.,
1993; Thibodeau, et al., 1993; Duggan et al., 1994; Mao et
al., 1994; Meltzer et al., 1994; Merlo et al., 1994; Mironov et
al., 1994; Rhyu et al., 1994; Shridhar et al., 1994; Uchida et
al., 1994; Wada et al., 1994). However, there are conflicting
reports concerning the presence of such alterations in
sporadic ovarian neoplasms (Dodson et al., 1993; Han et al.,
1993; Osborne and Leech, 1994; Wooster et al., 1994; King
BL, Carter D and Kacinski BM. Microsatellite instability in
tumours (unpublished data from The Fourth Meeting on the
Molecular Basis of Cancer, Frederick, MD, USA, June
1993)). One analysis of more than 20 microsatellite markers
failed to detect a single microsatellite alteration in any of 60
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sporadic epithelial ovarian tumours (Dodson et al., 1993).
Another comprehensive allelotype analysis of 25 sporadic
ovarian tumours at 68 different microsatellite loci revealed
only two alterations among the 1700 repetitive sequences
examined (Osborne and Leech, 1994). Together, these studies
indicated microsatellite instability to be an extremely uncom-
mon event in sporadic ovarian cancer. In contrast, another
smaller study reported dinucleotide alterations in 3/19 (16%)
ovarian tumours (Han et al., 1993). Interestingly, another
analysis failed to detect alterations at any of the six
dinucleotide loci examined, but identified mutations at higher
order tri- and tetranucleotide repeat sequences in 2 of the 20
ovarian tumours (Wooster et al., 1994).
The interpretation of these conflicting observations is par-
tially confounded by the variables of family history, tumour
histopathology and type of microsatellite marker studied.
Ovarian tumours occur with relatively high frequency in
some HNPCC pedigrees (Lynch et al., 1986), and tumour-
associated microsatellite instability has been observed in an
ovarian cancer patient with a germline hMSH2 mutation
(Orth et al., 1994). It is often difficult to obtain sufficient
family history to exclude the possibility that cases assembled
as sporadic are, in fact, from HNPCC pedigrees. Neither
detailed histories nor clinicopathological characteristics were
presented in two of the studies reporting tumour-associated
microsatellite instability in sporadic ovarian tumours (Han et
al., 1993; Wooster et al., 1994). The almost exclusive occur-
rence of alterations at higher order tri- and tetranucleotide
repeat sequences in one of these studies suggested that
features of the repeat loci themselves might be determinants
of tumour-associated instability (Wooster et al., 1994). In the
present study, we have analysed di- and tetranucleotide mic-
rosatellite loci in DNA from the neoplastic and non-
neoplastic tissues of 41 ovarian cancer patients characterised
for family history and clinicopathological features.
Materials and methods
Patients and specimens
The clinical and histopathological characteristics of the 41
ovarian cancer patients analysed for microsatellite instabilityMicrosatellite instability in ovarian cancer
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Table I Clinico
Ovarian tumour
histology
Endometrioid
adenocarcinoma
Mixed serous and
mucinous
adenocarcinoma
Malignant mixed
Mullerian tumour
Endometrioid
adenocarcinoma
Serous
adenocarcinoma
Immature
teratoma
Serous
adenocarcinoma
Serous
adenocarcinomaa
Serous
adenocarcinoma
Adenocarcinoma
with mixed
epithelial
elements
Serous
adenocarcinoma
Serous
adenocarcinoma
Endometrioid
adenocarcinoma
Serous
adenocarcinoma
Endometrioid
adenocarcinoma
Endometrioid
adenocarcinoma
Serous
adenocarcinoma
Malignant mixed
Muillerian tumour
Serous
adenocarcinoma
Serous
adenocarcinoma
Serous
adenocarcinoma
Dysgerminoma
Mixed serous and
mucinous
adenocarcinoma
Serous
adenocarcinoma
Serous
adenocarcinoma
Serous
adenocarcinoma
Endodermal sinus
tumour
Serous
adenocarcinoma
Serous
adenocarcinoma
Serous
adenocarcinoma
Serous
adenocarcinoma
Serous
adenocarcinoma
Serous
adenocarcinoma
Serous
adenocarcinoma
Serous
adenocarcinoma
Serous
adenocarcinoma
Dpathological characteristics of ovarian cancer patients
Micro FIGO Synchronous! Age
satellite stagel metachronous at
Instability grade tumours onset
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Noa/Yesb
No
No
No
No
No
No
No
No
No
No
No
No
No
No
No
No
No
No
No
No
No
No
No
No
No
No
No
No
1,2
I,.5
111,4
I,1
III,3
111,3
III,1
I,2
III,3
III,3
111,3
III,3
II1,2
III,1
II,1
III,1
III,3
111,4
I11,2/3
11,3
I11,2
IV,3
111,2
111,3
III,1
11,2
III
111,2
111,2
111,2
111,2
III,1
II,'
IV,3
111,3
III,3
No
Endometrium
No
No
Brenner tumour
Clear cell
ovarian
adenocarcinoma
No
Endometriumb
No
No
No
Breast
No
No
Endometrium
Lung,
endometrium,
breast
Endometrium
Endometrium
Endometrium
Endometrium
No
No
No
No
No
No
No
No
No
No
No
No
No
Breast
No
No
Patient no.
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
72
64
66
36
79
48
22
56
26
64
39
78
60
76
54
73
62
72
32
60
44
19
36
43
36
31
26
35
28
37
28
27
28
57
20
54
Family
history
Breast/
endometrium
Breast/
prostate
No
No
No
No
No
No
No
No
Breast/
liver
No
No
Breast
Not known
No
No
Not known
No
No
No
Breast
Ovary,
colon
Colon
No
No
No
No
No
No
No
No
No
Lung, brain
No
Ovary
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Table I Continued
Micro FIGO Synchronousl Age
Ovarian tumour satellite stagel metachronous at Family
Patient no. histology Instability grade tumours onset history
37 Mucinous No II1,2 No 38 Breast
adenocarcinoma
38 Mixed serous No IV,3 No 36 No
and mucinous
adenocarcinoma
39 Serous No III, No 19 No
adenocarcinoma .5
40 Serous No 111,3 No 37 Endometrium,
adenocarcinoma pancreas
41 Mixed serous No 111,3 No 45 Endometrium
and mucinous
adenocarcinoma
are presented in Table I. Nineteen cases were selected from
the archives of the Department of Pathology at the Yale
University Medical School, and 22 cases were obtained from
the Frauenklinik der Albert-Ludwigs-Universitiit of Freiburg.
Family history was determined by medical records. For the
Freiburg cases, positive family histories were confirmed by
histological diagnosis. Details on patients with positive
family histories are presented in Table II. Formalin-fixed,
paraffin-embedded archival specimens, including primary
tumour, metastatic deposits, lymph nodes and normal tissues,
were used for DNA extraction and microsatellite analysis.
Microdissection was performed on some sections to separate
neoplastic and non-neoplastic tissues. Serial H&E sections of
all tissues were reviewed by pathologists (MLC, DC and
JP).
DNA extraction
DNA extraction was performed according to Wright and
Manos, (1990). Five-micron-thick paraffin tissues were
scraped from histological slides, placed in Eppendorf tubes
and deparaffinised through successive rinses in 400,l
volumes of xylene and absolute and 95% ethanols. Tissues
were vortexed in each of these solutions for 15 s, and pelleted
by microcentrifugation at top speed for 10 min. The final
pellets were air dried overnight, resuspended in Manos buffer
(50 mM Tris pH 8.5, 1 mM EDTA, 0.5% Tween 20) and
incubated overnight at 37°C. Solutions were then heated to
95°C for 5 min, and next incubated with 200ygml-' Pro-
teinase K (Boehringer Mannheim, IN, USA) at 55°C for 3 h.
Proteinase K was then heat inactivated in a 5 min 95°C
incubation. Samples were stored at - 20°C until use.
Microsatellites
The following microsatellites were amplified in radiolabelled
polymerase chain reactions (PCRs) with the indicated
primers: (1) the tetranucleotide (GATA), GABARB1 locus
on chromosome 4pl2-13 (5'-tgatagctagaaagctagcaag-3'
and 5'-gctcattaaacactgtgttcct-3') (Dean et al., 1991); and (2)
the dinucleotide (CA)" Mfd 27 locus on chromosome
5ql 1-13 (5'-gatccactttaacccaaatac-3' and 5'-ggcatcaacttg
aacagcat-3') (Weber et al., 1990).
PCR
PCRs were performed according to the specifications of the
Perkin-Elmer Cetus Gene-Amp PCR reagent kit (Norwalk,
CT, USA) with minor modifications. Briefly, 5 il of the
above DNA solutions was used for each 50fld PCR reaction
containing 1 x reaction buffer, 1.25 units ofAmpliTaq DNA
polymerase, 20 ng of each primer and 200 tiM each of dCTP,
dGTP and dTTP. The concentration of cold dATP per reac-
tion was reduced to 50 ELM, and 2.5 gLCi [35S]dATP (DuPont,
NEN Products, Boston, MA, USA) was added. The reaction
mixtures were cycled in a Perkin-Elmer Cetus DNA thermal
Table II Microsatellite instability and family history
Ovarian Microsatellite
patient no. Tumour/relative(s) instability
I Breast-sister Yes
Endometrium-sister
2 Breast-sister Yes
Prostate-brother
11 Breast-maternal aunt, paternal No
grandmother
Liver-father
14 Breast-ten female relatives No
22 Breast-grandmother No
23 Ovary-mother, grandmother No
Colon-father, grandmother
24 Colon-father, paternal grandmother, No
great grandmother
34 Lung-uncle No
Brain-brother
36 Ovary-mother, sister No
37 Breast-mother, sister No
40 Endometrium-aunt No
Pancreas-grandmother
41 Endometrium-mother, two aunts, two No
cousins, two nieces
cycler for 35 cycles consisting of a 1 min denaturing step at
94°C, a 1 min annealing step at 55°C and a 1 min extension
step at 72°C. Ten microlitres ofeach completed PCR reaction
were then mixed with S 1tl of sequencing stop solution (95%
formamide, 20 mM EDTA, 0.05% bromphenol blue, 0.05%
xylene cyanol; United States Biochemical, Cleveland, OH,
USA), and heat denatured at 80°C for 3 min. Three mic-
rolitre volumes ofthe denatured samples were resolved in 6%
denaturing polyacrylamide sequencing gels (Sequagel,
National Diagnostics, Manville, NJ, USA) subjected to
1500 V for 2.5 h. The gels were fixed in a 10%
methanol- 10% acetic acid solution for 1 h, heat dried in a
vacuum gel drying apparatus and then autoradiographed
using X-OMAT autoradiographic film (Kodak, Rochester,
NY, USA) for 1-7 days.
Statistics
Statistical comparison of mutation frequencies associated
with clinicopathological features was performed using
Fisher's exact test.
Results
Microsatellite alterations
Microsatellite instability was observed in the malignant tis-
sues of 7/41 (17%) of the ovarian cancer patients studied. Inall cases, alterations consisted of one or more additional
novel alleles (Figure 1). More than one additional novel allele
was observed in three ofthe tumours. Two of the seven novel
alleles were larger than the wild-type allele, four were smaller
and one was intermediate in length between the two wild-
type alleles. In two of the cases, the novel allele differed by
more than one repeat unit from the wild-type allele (Figure
2). Analysis of DNAs extracted from separate serial paraffin
tissue sections was performed on six of the cases with altera-
tions, confirming them in all cases.
All seven of the cases characterised for instability exhibited
alterations at the tetranucleotide GABARBI locus. Two of
these cases (nos. 1 and 3) were found to exhibit instability at
the dinucleotide Mfd 27 locus as well. One of the patients
(no. 8) was diagnosed with synchronous tumours of the
ovary and uterus. In this case, alterations were observed at
both loci in the uterine tumour, but at neither in the ovarian
tumour. In case no. 6, a novel allele was observed in the
primary tumour, but not in a metastatic deposit (Figure 1).
In case no. 2, a novel allele was observed in the DNA
derived from one region of the ovarian tumour, but was
absent in DNA derived from a remote region of the same
tumour.
Familial disease
Family histories were obtained for 39 of the patients, twelve
of whom were found to have relatives with cancer (Table II).
Tumour-associated microsatellite instability was observed in
2/12 (17%) of these patients (nos. 1 and 2) vs 5/27 (18%) of
the patients with negative histories (P>0.1). Patient no. 1
Ir IL I a1 'r ki 11 Ki AA IU ir I hl
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Figure 1 Autoradiograph demonstrating GABARB1 tet-
ranucleotide microsatellite instability in three ovarian cancer
patients: case no. 1 (left), case no. 6 (middle) and case no. 3
(right). DNAs were extracted from neoplastic and non-neoplastic
tissues, amplified by radiolabelled PCR, and resolved in denatur-
ing polyacrylamide gels. Arrows denote novel alleles. T, tumour;
N, normal; M metastasis; L, lymph node.
T L N
Figure 2 GABARBI profiles for tumour (T), lymph node (L)
and normal (N) tissues from ovarian cancer patient no. 4. The
two wild-type alleles are denoted by small arrows, and two
additional wild-type alleles are shown with large arrows. The
novel alleles differ in length from the wild-type alleles by 8 and
16 bases. This pattern suggests that large loops may have been
generated during microsatellite slippage events.
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had a positive family history for breast and endometrial
cancer, and patient no. 2 had a positive family history for
breast and prostate cancer. The remaining ten patients with
positive family histories had relatives with a variety ofmalig-
nancies, including ovarian, breast, endometrial and colon
(Table II). One of these patients (no. 24) belonged to a
pedigree fitting the classic definition of HNPCC, but was not
observed to have tumour-associated microsatellite alterations.
Twenty-five of the 41 patients (61%) were diagnosed with
ovarian tumours before the age of 50. Tumours from three of
these patients (12%) had microsatellite alterations, whereas
tumours from 4/16 (25%) of the patients diagnosed after 50
were found to have such alterations (P>0.1). Eleven patients
were diagnosed with synchronous or metachronous tumours,
and three of these (27%) were found to have microsatellite
instability, whereas 4/30 (13%) without multiple primary
neoplasms had tumour-associated microsatellite instability
(P>0.1).
Pathology
The clinicopathological features of the tumours studied are
presented in Table I. Twenty-four of the 36 epithelial ovarian
neoplasms were classified as serous adenocarcinomas. Only
two of these (2/24 or 8%) were found to have microsatellite
alterations. The remaining five tumours in which microsatel-
lite instability was observed were classified as endometrioid
carcinomas (2), mixed serous and mucinous carcinomas (1),
malignant mixed Miillerian tumour (1) and immature
teratoma (1) (Table III). Five of the 36 (13%) epithelial vs
two out of five (40%) non-epithelial tumours had microsatel-
lite alterations. Thirty of the tumours studied were classified
as FIGO stage III at presentation, of which four (13%) had
alterations. None of the four stage II and none of the three
stage IV tumours were found to have alterations. However,
three of the four (75%) stage I presentations were charac-
terised as positive for microsatellite instability (P = 0.01).
Normal tissues
No alterations were found in any of the non-neoplastic tis-
sues analysed from this group of patients, with two excep-
tions. Two lymph nodes (from patients 3 and 4), charac-
terised as histopathologically negative for metastatic involve-
ment, were found to have microsatellite mutation patterns
identical to those observed in the primary ovarian tumours
(Figure 1). H&E staining failed to demonstrate the presence
of epithelial elements, and immunohistochemical analysis
failed to detect cells positive for cytokeratins Al and A3 in
either node. However, both of these lymph nodes were mas-
sively infiltrated by histiocytes. The presence of novel mic-
rosatellite alleles in the DNAs extracted from these nodes
was interpreted as likely to have been derived from the
residual DNA of phagocytosed ovarian carcinoma cells.
Discussion
We originally analysed microsatellites for the purpose of
fingerprinting ovarian tumour cell lines (King et al., 1994),
and became curious about the general stability of these
sequences in vitro and in vivo. We proceeded to study the
Table III Frequencies of microsatellite alterations according to
histological classification
Epithelial
Serous adenocarcinoma 2/24
Endometrioid adenocarcinoma 2/5
Mixed serous and mucinous carcinoma 1/4
Other 0/3
Non-epithelial
Malignant mixed Mullerian 1/2
Immature teratoma 1/3cMkmsatelite instability in ovadan cancer
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GABARBI tetranucleotide locus in the tissues of a small
group ofovarian cancer patients, and observed several altera-
tions in the malignant tissues (King et al., 1993, unpublished
data). However, these observations appeared to contradict a
larger analysis of 60 sporadic ovarian tumours which failed
to detect alterations at any of the more than 20 repeat loci
examined (Dodson et al., 1993). Subsequent studies, inves-
tigating microsatellite instability in multiple tumour types,
reported alterations in 3/20 (16%) and 2/20 (10%) of the
ovarian tumours (Han et al., 1993; Wooster et al., 1994). The
overall frequency of alterations observed in the present study
(7/41 or 17%) is consistent with these two studies. Possible
explanations of the divergent observations involve the
variables of family history, microsatellite repeat features and
tumour histology.
Although most ovarian cancer is thought to be sporadic,
familial aggregation is recognised in three types of pedigrees
(Lynch et al., 1986; DiCioccio and Piver, 1992): (1) those
with a high frequency of ovarian neoplasms alone; (2) those
in which there is a high frequency of both ovarian and breast
cancer; and (3) those characterised by a high frequency of
adenocarcinomas of the colon, endometrium and ovary (e.g.
HNPCC). In our study, family histories were available for 39
of the patients, and 12 of these patients had relatives with
cancer (Table II). One patient had a family history meeting
the Amsterdam criteria for HNPCC syndrome, i.e. three
cases of colon cancer among closely related members of
successive generations, with at least one case being diagnosed
before the age of 50 (Vasen et al., 1991). This patient was not
found to have tumour-associated microsatellite instability.
The other patients with positive family histories had relatives
with a variety of malignancies, including ovarian, breast,
endometrial and prostatic cancer (Table II). In all, tumour-
associated microsatellite alterations were observed in only
2/12 (17%) of these patients. Similarly, the frequency of
alterations was not significantly higher among patients with
other clinical features suggestive of familial cancer, such as
diagnosis before the age of 50 (12%) and the presence of
synchronous or metachronous tumours (27%). Microsatellite
instability did not, therefore, appear to be exclusively
associated with features of familial ovarian cancer. Analyses
of the hMSH2 and hMLHI genes are currently being per-
formed on the DNAs from cases showing tumour-associated
microsatellite instability to determine if these patients have
germline and/or somatically acquired mutations at these
loci.
In theory, the frequency of detected microsatellite altera-
tions depends on both the mutability of the repeat sequences
under study and the proficiency of DNA replication and
repair activities of the cells which contain them. HNPCC
tumours have been characterised by the genome-wide altera-
tion of dinucleotide repeat sequences, a form of instability
attributed to mutations in a number of mismatch repair
genes (hMSH2, hMLHI, hPMSI and hPMS2) (Fishel et al.,
1993; Leach et al., 1993; Bronner et al., 1994; Nicolaides et
al., 1994; Papadopoulos et al., 1994). In contrast, a different
pattern of instability has been observed in a variety of non-
HNPCC tumours, in which alterations were found with
lower frequency, and almost exclusively at higher order tri-
and tetranucleotide repeats (Wooster et al., 1994). This pat-
tern could result from two distinct phenomena. First, excep-
tionally high germline mutation rates have been observed for
tetranucleotide repeat sequences (Mahtani and Willard, 1993;
Weber and Wong, 1993). The exclusive detection of altera-
tions at these loci may reflect a more subtle form of the
repair deficiency that generates genome-wide dinucleotide in-
stability in HNPCC tumours (Wooster et al., 1994). Alterna-
tively, recent in vitro observations suggest that small mis-
matches and large loops resulting from slippage events at
repeat sequences may be recognised and repaired by different
components of the DNA mismatch repair machinery (Umar
et al., 1994b). Small mismatches involving only a few bases
would be more likely to arise in misaligned dinucleotide
repeats, whereas large loops are more likely to result from
slippage at tri- and tetranucleotide repeats. The novel tet-
Endometrial
KA KA T KM M KI
Ovarian
T N N
Di
retra
Figure 3 Simultaneous tetra- and dinucleotide microsatellite
alterations in endometrial (case no. 8) and ovarian (case no. 1)
tumours. T, tumour; N, normal; M, metastasis.
ranucleotide alleles shown in Figure 2 differ in length from
the wild-type alleles by 8 and 16 bases respectively, and could
have resulted from a defect in large loop repair. Although we
have observed di- and tetranucleotide instability simul-
taneously in some tumours (Figure 3), a subset of malignan-
cies, including some sporadic ovarian neoplasms, may be
specifically defective for large loop repair activity.
Ovarian neoplasms constitute a group of his-
topathologically diverse tumours. Most ovarian tumours, in-
cluding the most frequently diagnosed serous adenocar-
cinomas, are thought to originate from the surface epithelium
(Young et al., 1989). A smaller percentage of ovarian neop-
lasias, e.g. teratomas, arise from the germ cells. Other rare
tumours, such as malignant mixed Mullerian tumours, are
composed of multiple cell lineages thought to arise from
embryologically pluripotent cells. Interestingly, microsatellite
instability was observed in more than half of these uncom-
mon tumour types, and much less frequently in the more
common serous adenocarcinomas (Table III). The two pub-
lished studies reporting negligible frequencies ofmicrosatellite
alterations were done on epithelial ovarian carcinomas (Dod-
son et al., 1993; Osborne and Leech, 1994), whereas his-
topathological classification was not provided in the studies
reporting alterations (Han et al., 1993; Wooster et al., 1994).
Histopathological classification may thus explain some of the
discrepancies regarding microsatellite instability in ovarian
cancer. Another interesting clinicopathological correlation
was a positive association of microsatellite instability with
the small number of stage I tumour presentations. Similar
associations, linking alterations to low-stage disease and
favourable patient prognosis, have been reported for colorec-
tal tumours (Lothe et al., 1993; Thibodeau et al., 1993), and
it has been suggested that the extensive genetic instability
associated with microsatellite alterations may ultimately com-
promise tumour progression (Radman and Wagner, 1993). In
short, our observations suggest that histological subtype and
clinical stage may be determinants of microsatellite instability
in ovarian neoplasms.
In conclusion, we have observed microsatellite instability
in the neoplastic tissues of 7/41 (17%) ovarian cancer
patients characterised for diverse genetic backgrounds and
clinicopathological characteristics. Since ovarian cancer can
be a manifestation of the HNPCC syndrome, it is possible
that at least some of the patients in our study could be
members of such pedigrees. This is particularly likely for
patient no. 1, who had a positive family history of HNPCC-
associated cancers and who was found to have alterations at
di- and tetranucleotide repeat loci. However, tumour-
associated microsatellite instability was also observed in aMicrosatelifte instability in ovarian cancer
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number of patients without features of familial disease. The
pattern of observed alterations suggests that multiple
molecular mechanisms may be associated with the generation
of microsatellite instability in ovarian neoplasms.
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